Marc Teitelbaum MD, MS

Director of Clinical Safety, Leidos Biomedical Research, Inc. [Supporting NIAID/NIH]

Dr. Teitelbaum received his Masters in Health Sciences from SUNY Stony Brook and his MD from SUNY Downstate. Prior to his medical career he was a systems and operations analyst and a manager at the New York City Emergency Medical Service, Doubleday and Co., and JP Morgan. Dr. Teitelbaum has been with Leidos Biomed for 6 years, initially supporting the Cancer Imaging Program at the National Cancer Institute in a Quality Assurance role. Currently he serves as Director of Clinical Safety in the Regulatory Compliance and Human Subjects Protection Program supporting the National Institute of Allergy and Infectious Diseases and other NIH Institutes. He has also served on a national IRB as a board member and a designee for expedited review for several years.

Dr. Teitelbaum is, in part, standing in at ACRP for Dr. Terry Mainprize, co-author of the Poster, who passed away recently.


This speaker has made no appearances.